Penumbra Inc’s recently made public that its EVP, Gen. Counsel & Secretary Roberts Johanna unloaded Company’s shares for reported $0.18 million on Dec 01 ’25. In the deal valued at $294.94 per share,600 shares were sold. As a result of this transaction, Roberts Johanna now holds 64,136 shares worth roughly $18.91 million.
Then, Grewal Harpreet sold 100 shares, generating $29,298 in total proceeds. Upon selling the shares at $292.98, the Director now owns 8,416 shares.
Before that, Grewal Harpreet bought 100 shares. Penumbra Inc shares valued at $29,298 were divested by the Director at a price of $292.98 per share.
Wells Fargo initiated its Penumbra Inc [PEN] rating to an Underweight in a research note published on November 18, 2025; the price target was $15. A number of analysts have revised their coverage, including Needham’s analysts, who increased its forecast for the stock in early October from “a Hold” to “a Buy”. Evercore ISI began covering PEN with “an Outperform” recommendation on September 02, 2025. BofA Securities started covering the stock on March 14, 2025. It rated PEN as “a Buy”.
Price Performance Review of PEN
On Monday, Penumbra Inc [NYSE:PEN] saw its stock fall -1.94% to $294.83. Over the last five days, the stock has gained 1.09%. Penumbra Inc shares have risen nearly 18.37% since the year began. Nevertheless, the stocks have risen 24.15% over the past one year. While a 52-week high of $310.00 was reached on 02/19/25, a 52-week low of $221.26 was recorded on 11/03/25.
Levels Of Support And Resistance For PEN Stock
The 24-hour chart illustrates a support level at 290.89, which if violated will result in even more drops to 286.95. On the upside, there is a resistance level at 300.23. A further resistance level may holdings at 305.64.
How much short interest is there in Penumbra Inc?
A steep rise in short interest was recorded in Penumbra Inc stocks on 2025-11-14, dropping by 46147.0 shares to a total of 1.69 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-15 was 1.73 million shares. There was a decline of -2.73%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on January 21, 2025 when UBS began covering the stock and recommended ‘”a Buy”‘ rating along with a $305 price target.
